KALV — KALVISTA PHARMACEUTICALS INC

Ownership history in DRW Securities, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which DRW Securities, LLC reported a position in KALVISTA PHARMACEUTICALS INC (KALV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2017 Q4)
Avg. % of fund
0.01%
First filed
2017 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 16,775 -3,825 -18.6% 0.00% $196K $12.18
2018 Q2 ADDED 20,600 +5,600 +37.3% 0.01% $167K $8.12
2018 Q1 ADDED 15,000 +3,000 +25.0% 0.01% $142K $9.48
2017 Q4 INITIATED 12,000 — — 0.01% $117K —
% of Fund (quarterly)    KALV price (monthly, adj. close)

Other funds also holding KALV

As of 2025 Q4 — sorted by position size

SILVERARC CAPITAL MANAGEMENT, LLC 3Y 5.44% VR Adviser, LLC 3Y 5.37% Elmind Capital, LP 3.82% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 3.65% GREAT POINT PARTNERS LLC 3Y 7Y 3.59% Parkman Healthcare Partners LLC 3Y 2.72% Octagon Capital Advisors LP 3Y 2.5% Frazier Life Sciences Management, L.P. 3Y 2.19% Kynam Capital Management, LP 3Y 1.87% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.58%
← Back to DRW Securities, LLC Holdings